Clinical and pathological features and the BRAFV600E mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis

Thyroid

Volumn 19, Issue 2, 2009, Pages 137-141

  Kim, Suk Kyeong ^a   Song, Kee Ho ^a   Lim, So Duk ^a   Lim, Young Chang ^a   Yoo, Young Bum ^a   Kim, Ji Soo ^b   Hwang, Tae Sook ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; THYROID CARCINOMA; TUMOR VOLUME;

ADULT; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; FEMALE; HASHIMOTO DISEASE; HUMANS; KOREA; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 59649102702     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0144     Document Type: Article

References (26)

1. National Cancer Centre, Korea 2003 2002 annual report of the Korea Central Cancer Registry. http://www.ncc.re.kr (last accessed February 2005).
2. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E 1985 The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules. Surgery 98:1202-1206.
3. Ott RA, McCall AR, McHenry C, Jarosz H, Aemin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-425.
4. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL 1997 Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107:95-100.
5. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE 2003 Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link? Hum Pathol 34:764-769.
6. Melillo RM, Castellone MD, Guarino V, de Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhofer M, Orntft T, Fusco A, Santoro M 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the nmotile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081.
7. Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM 1998 Prevalences of Gs alpha, ras, p53 mutations and RET/PTC rearrangement in differentiated thyroid tumors in a Korean population. Clin Endocrinol 49:317-323.
8. Chung JH, Hahm JR, Min YK, Lee MS, Lee MK, Kim KW, Nam SJ, Yang JH, Ree HJ 1999 Detection of RET/PTC oncogene rearrangement in Korean papillary thyroid carcinomas. Thyroid 9:1237-1243.
9. Xing M 2005 BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-262.
10. Kim KH, Kang DW, Kim SH, Seong IO, Kang DY 2004 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45:818-821.
11. Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK 2006 The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol 65:364-368.
12. V600E mutation-prevalent area. Clin Endocrinol (Oxf ) 65:660-666.
13. Knauf JA, Ma X, Smith EP, Zhang L, Mitsutake N, Nikiforov YE, Fagin JA 2004 Targeted expression of BRAFV600E in thyroid cells of transgenicmice results in papillary thyroid cancers that transition to undifferentiated carcinomas. The 76th American Thyroid Association Annual Meeting, Vancouver, British Columbia, Canada. Abstract, short-call program #2.
14. Kim KH, Suh KS, Kang DS, Kang DY 2005 Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathol Int 55:540-545.
15. Koh CS, Ku JL, Park SY 2007 Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene. Mol Cell Endocrinol 264:118-127.
16. Dailey ME, Lindsay S, Skahen R 1955 Relation of the thyroid neoplasm to Hashimoto's disease of the thyroid gland. Arch Surg 70:291-297.
17. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1077.
18. Stephenson TJ 2001 Papillary carcinoma of the thyroid: a tumour still with no benign neoplastic counterpart. Histopathology 39:536-538.
19. Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS 2007 High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 11:1031-1037.
20. Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL 2006 BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 17:235-241.
21. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463.
22. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424.
23. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
24. Kevebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A 2007 The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 246:466-471.
25. Lee JH, Lee ES, Kim YS 2007 Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer 110:38-46.
26. Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS 2008 Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 17:118-125.